Polyamine-low Diet to Prevent Postoperative Pain After Cholecystectomy

NCT ID: NCT02083003

Last Updated: 2016-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It has been shown that N-methyl-D-aspartate (NMDA) receptor antagonists (such as ketamine) potentiate analgesic drug's efficacy. Polyamines are allosteric modulators of NMDA receptors. In animal studies, polyamine-free diet has shown antinociceptive properties. This research aims at evaluating analgesic properties of polyamine-low diet after laparoscopic cholecystectomy performed in an ambulatory setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgery

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Pain Polyamine Cholecystectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Polyamine low-diet

Polyamines depleted diet during the week before surgery : 2 cans per day of Polydol (oral alimentation without polyamines), associated to predefined menus low in polyamines

Group Type EXPERIMENTAL

Polyamine low-diet

Intervention Type DIETARY_SUPPLEMENT

Liberal alimentation

No specific alimentary diet

Group Type ACTIVE_COMPARATOR

Liberal alimentation

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Polyamine low-diet

Intervention Type DIETARY_SUPPLEMENT

Liberal alimentation

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Poyldol plus (Nutrialys) No specific alimentary recommendation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* laparoscopic cholecystectomy
* ambulatory surgery
* agreeing to follow a polyamine-low diet with Polydol plus

Exclusion Criteria

* Pregnancy
* Contra-indication to a non-steroidal anti-inflammatory, to tramadol
* Intolerance to cow proteins
* Diabetic patients
* Poor understanding of the French language.
Minimum Eligible Age

18 Years

Maximum Eligible Age

76 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hopital Foch

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marc Fischler, MD

Role: STUDY_CHAIR

Hopital Foch

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital de la Croix Saint-Simon

Paris, Hauts de Seine, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-A01675-36

Identifier Type: OTHER

Identifier Source: secondary_id

2011/68

Identifier Type: -

Identifier Source: org_study_id